Business & Regulation

From surge to stumble and back again, seven cell and gene legends recount their personal favorite breakthroughs in the field.

We speak to one of advanced therapy’s great minds about analog and digital events, and the future of the field.

To see continued progress, the pharma and tech industries must collaborate.

We asked the field’s greatest minds: “What improvements do we need to see in cell and gene supply chains?”

How will bureaucratic red tape affect pharma’ ability to support women seeking abortions?

Diversity, support networks, and unexpected journeys: what nine years of C&G biz wisdom can teach us

What role must pharma play to help improve outcomes for women?

Nuvolo was crowned the grand winner of the 2021 Innovation Awards. We find out what makes their software so special.

Can cell and gene therapy help bring an end to rare eye diseases?

Five members of The Medicine Maker’s 2022 Power List share their thoughts on how the pharma industry can improve.